chartexchange

Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference

GlobeNewswire Inc. | Oct 14, 2026 8:00 AM EDT

HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will present at Chardan’s 10 th Annual Healthcare Conference in New York City on Tuesday, October 20, 2026, at 1:30 PM ET.

Read original article